Dr. Tonya D. Russell, MD

Dr. Russell practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Russell's NPI, 1194743906, was assigned on July 18, 2006. Dr. Russell graduated from University of Florida College of Medicine in 1997. Dr. Russell holds Missouri license 112895.

Dr. Russell's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Russell also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Russell's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Russell is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Russell to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Russell practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Russell's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Russell is licensed in Missouri.

CMS data shows 1,624 Medicare services from Dr. Russell across 20 procedure codes in 2024, for 737 Medicare patients. Medicare paid $76,597 for them.

CMS counts 737 Medicare patients who saw Dr. Russell in 2024. The largest group is 65 to 74, with 355 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Russell's median patient age at 69, with 57% women.

In 2024, Dr. Russell wrote 2,542 Medicare Part D claims for 385 patients. 54% of them were for generic drugs. CMS names the drug for 2,295 of them, across 41 drugs with 11 or more claims each, at $3,258,537 in total drug cost. In 2023, CMS named 1,984 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Russell for performance year 2024, reported as part of a group. Dr. Russell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Russell as offering telehealth.

Dmand AI links 5 papers to Dr. Russell, published from 2011 to 2017. Dr. Russell's most frequent co-authors are Adrian Shifren, MD, Jeffrey J. Atkinson, MD and Sanjeev Bhalla, MD.

Dmand AI links Dr. Russell to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis. Open Payments lists research payments to Dr. Russell that name 1 trial.

CMS Open Payments shows 3 general payments to Dr. Russell from 3 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 94% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $143. It also lists 14 research payments totaling $1,418 in 2024, naming 1 clinical trial.

Dr. Russell graduated from University of Florida College of Medicine in 1997.